Home NDC 82448-100 OGSIVEO
Product NDC 82448-100
11-digit product format 824480100
Labeler code 82448
Product ID 82448-100_39192daa-3e54-4741-adad-7d3742860396
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name nirogacestat
Dosage form TABLET, FILM COATED
Route ORAL
Labeler SpringWorks Therapeutics, Inc.
Application NDA217677
Marketing category NDA
Marketing start 2023-11-27
Substance NIROGACESTAT
Active strength 100 mg/1
Pharmacologic classes Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], Gamma Secretase Inhibitor [EPC], Gamma Secretase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N217677-001 OGSIVEO NIROGACESTAT HYDROBROMIDE EQ 50MG BASE TABLET / ORAL RLD 2023-11-27 N217677-002 OGSIVEO NIROGACESTAT HYDROBROMIDE EQ 100MG BASE TABLET / ORAL RLD 2024-04-04 N217677-003 OGSIVEO NIROGACESTAT HYDROBROMIDE EQ 150MG BASE TABLET / ORAL RLD, RS 2024-04-04
Orange Book patents# Current patent rows page 1 of 2 · 87 matching rows.
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 6 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 48 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217677-001 OGSIVEO EQ 50MG BASE TABLET / ORAL RLD 2023-11-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-002 OGSIVEO EQ 100MG BASE TABLET / ORAL RLD 2024-04-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-003 OGSIVEO EQ 150MG BASE TABLET / ORAL RLD, RS 2024-04-04 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217677-001 OGSIVEO EQ 50MG BASE TABLET / ORAL RLD 2023-11-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217677-002 OGSIVEO EQ 100MG BASE TABLET / ORAL RLD 2024-04-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217677-003 OGSIVEO EQ 150MG BASE TABLET / ORAL RLD, RS 2024-04-04 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217677-001 OGSIVEO EQ 50MG BASE TABLET / ORAL RLD 2023-11-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217677-002 OGSIVEO EQ 100MG BASE TABLET / ORAL RLD 2024-04-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217677-003 OGSIVEO EQ 150MG BASE TABLET / ORAL RLD, RS 2024-04-04 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217677-001 OGSIVEO EQ 50MG BASE TABLET / ORAL RLD 2023-11-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217677-002 OGSIVEO EQ 100MG BASE TABLET / ORAL RLD 2024-04-04 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217677-003 OGSIVEO EQ 150MG BASE TABLET / ORAL RLD, RS 2024-04-04 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217677-001 OGSIVEO EQ 50MG BASE TABLET / ORAL RLD 2023-11-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217677-002 OGSIVEO EQ 100MG BASE TABLET / ORAL RLD 2024-04-04 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217677-003 OGSIVEO EQ 150MG BASE TABLET / ORAL RLD, RS 2024-04-04 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217677-001 OGSIVEO EQ 50MG BASE TABLET / ORAL RLD 2023-11-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217677-002 OGSIVEO EQ 100MG BASE TABLET / ORAL RLD 2024-04-04 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217677-003 OGSIVEO EQ 150MG BASE TABLET / ORAL RLD, RS 2024-04-04 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217677-001 OGSIVEO EQ 50MG BASE TABLET / ORAL RLD 2023-11-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217677-002 OGSIVEO EQ 100MG BASE TABLET / ORAL RLD 2024-04-04 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217677-003 OGSIVEO EQ 150MG BASE TABLET / ORAL RLD, RS 2024-04-04 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N217677-001 OGSIVEO EQ 50MG BASE TABLET / ORAL RLD 2023-11-27 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N217677-002 OGSIVEO EQ 100MG BASE TABLET / ORAL RLD 2024-04-04 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N217677-003 OGSIVEO EQ 150MG BASE TABLET / ORAL RLD, RS 2024-04-04 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N217677-001 OGSIVEO EQ 50MG BASE TABLET / ORAL RLD 2023-11-27 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N217677-002 OGSIVEO EQ 100MG BASE TABLET / ORAL RLD 2024-04-04 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N217677-003 OGSIVEO EQ 150MG BASE TABLET / ORAL RLD, RS 2024-04-04 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N217677-001 OGSIVEO EQ 50MG BASE TABLET / ORAL RLD 2023-11-27 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N217677-002 OGSIVEO EQ 100MG BASE TABLET / ORAL RLD 2024-04-04 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N217677-003 OGSIVEO EQ 150MG BASE TABLET / ORAL RLD, RS 2024-04-04 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N217677-001 OGSIVEO EQ 50MG BASE TABLET / ORAL RLD 2023-11-27 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N217677-002 OGSIVEO EQ 100MG BASE TABLET / ORAL RLD 2024-04-04 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N217677-003 OGSIVEO EQ 150MG BASE TABLET / ORAL RLD, RS 2024-04-04 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N217677-001 OGSIVEO EQ 50MG BASE TABLET / ORAL RLD 2023-11-27 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N217677-002 OGSIVEO EQ 100MG BASE TABLET / ORAL RLD 2024-04-04 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N217677-003 OGSIVEO EQ 150MG BASE TABLET / ORAL RLD, RS 2024-04-04 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N217677-001 OGSIVEO EQ 50MG BASE TABLET / ORAL RLD 2023-11-27 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N217677-002 OGSIVEO EQ 100MG BASE TABLET / ORAL RLD 2024-04-04 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N217677-003 OGSIVEO EQ 150MG BASE TABLET / ORAL RLD, RS 2024-04-04 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N217677-001 OGSIVEO EQ 50MG BASE TABLET / ORAL RLD 2023-11-27 8072bd15b7f6…
Observed Orange Book patent history# Patent history page 1 of 31 · 1,205 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217677-001 7795447 2030-08-18 Drug substance 2023-12-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-001 10590087 2039-08-09 Drug substance 2023-12-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-001 10710966 2039-08-09 U-3754 Drug substance 2023-12-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-001 10941118 2039-08-09 U-3754 Drug substance 2023-12-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-001 11820748 2039-08-09 Drug product 2023-12-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-001 11845732 2039-08-09 U-3754 Drug substance 2023-12-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-001 11884634 2039-08-09 Drug product 2024-01-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-001 11884635 2039-08-09 Drug product 2024-01-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-001 11905255 2039-08-09 Drug product 2024-02-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-001 12116347 2039-08-09 Drug product 2024-10-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-001 12297177 2039-08-09 Drug product 2025-05-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-001 11504354 2042-07-08 Drug product 2023-12-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-001 11612588 2042-07-08 U-3754 Drug product 2023-12-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-001 12110277 2042-07-08 Drug product 2024-10-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-001 12234210 2042-07-08 Drug product 2025-03-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-001 12247012 2042-07-08 Drug product 2025-03-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-001 11807611 2042-09-08 U-3754 Drug product 2023-12-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-001 11844780 2042-09-08 U-3754 Drug product 2023-12-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-001 11872211 2043-05-19 U-3754 2024-01-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-001 11925619 2043-05-19 U-3754 2024-03-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-001 11925620 2043-05-19 U-3754 2024-03-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-001 11938116 2043-05-19 U-3754 2024-03-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-001 11951096 2043-05-19 U-3754 2024-04-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-001 11957662 2043-05-19 U-3754 2024-04-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-001 12011434 2043-05-19 U-3754 2024-06-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-001 12011435 2043-05-19 U-3754 2024-06-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-001 12036207 2043-05-19 U-3754 2024-07-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-001 12138246 2043-05-19 U-3754 2024-11-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-002 7795447 2030-08-18 Drug substance 2024-04-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-002 10590087 2039-08-09 Drug substance 2024-04-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-002 10710966 2039-08-09 U-3754 Drug substance 2024-04-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-002 10941118 2039-08-09 U-3754 Drug substance 2024-04-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-002 11820748 2039-08-09 Drug product 2024-04-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-002 11845732 2039-08-09 U-3754 Drug substance 2024-04-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-002 11884634 2039-08-09 Drug product 2024-04-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-002 11884635 2039-08-09 Drug product 2024-04-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-002 11905255 2039-08-09 Drug product 2024-04-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-002 12116347 2039-08-09 Drug product 2024-10-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-002 12297177 2039-08-09 Drug product 2025-05-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217677-002 11504354 2042-07-08 Drug product 2024-04-12 011fe1cb6892…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 3 · 94 observed states.
Additional Listing Data#
Finished product Yes
Brand name base OGSIVEO
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength NIROGACESTAT 100 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination QZ62892OFJ Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 8 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2680360 Internal RxNorm lookup 2680362 Internal RxNorm lookup 2680363 Internal RxNorm lookup 2680364 Internal RxNorm lookup 2680366 Internal RxNorm lookup 2680368 Internal RxNorm lookup 2680369 Internal RxNorm lookup 2680370 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 82448-100-14 OGSIVEO 14 in 1 BLISTER PACK TABLET, FILM COATED 14 14
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 82448-100 OGSIVEO (NIROGACESTAT) TABLET, FILM COATED [SPRINGWORKS THERAPEUTICS, INC.] 9 Current NDC, 1 package rows 20241123_f172e6ff-3190-41b0-b95a-58a7ef9e9e1e.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 82448-100-14 82448010014 14 TABLET, FILM COATED in 1 BLISTER PACK (82448-100-14) 2023-11-27 No No Current